Vimarsana
Biggest News Aggregation in the World

Page 3 - Project Accelerate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project Accelerate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Accelerate Today - Breaking & Trending Today

Bruker Corporation (NASDAQ:BRKR) Q3 2023 Earnings Call Transcript - Vimarsana News

Bruker Corporation (NASDAQ:BRKR) Q3 2023 Earnings Call Transcript

Justin Ward: Thank you and good morning. I would like to welcome everyone to Bruker Corporation’s third quarter 2023 earnings conference call.

Allergan Aesthetics and Girls Inc. Partner to Speed the Entry of Young Women into Positions of Leadership in the STEM Field - Vimarsana News

Allergan Aesthetics and Girls Inc. Partner to Speed the Entry of Young Women into Positions of Leadership in the STEM Field

Today Allergan Aesthetics, an AbbVie company, announces its fifth year of partnership with Girls Inc., this year supporting Project Accelerate, a program addressing inequality in the workplace that aims to accelerate young women's trajectories through college and career entry. The Allergan Aesthetics effort will ...

Allergan Aesthetics invests in women's career trajectories to close STEM gap - Vimarsana News

Allergan Aesthetics invests in women's career trajectories to close STEM gap

Through the partnership, women involved in Project Accelerate will have access to internship and early-career opportunities at AbbVie and Allergan Aesthetics.

Girls Inc. of Orange County' aids in the college transition - Vimarsana News

Girls Inc. of Orange County' aids in the college transition

Through its College Bound program, the nonprofit helps dozens of teenage girls navigate this stressful period and helps them pay for it. The deadline to apply for this year's program is Wednesday, Sept. 13.

Bruker to acquire Phenomex for $108M in cash - Vimarsana News

Bruker to acquire Phenomex for $108M in cash

Bruker Corp. signed a definitive agreement to acquire functional cell biology company Phenomex for $108 million as part of its Project Accelerate 2.0 strategy, which increases focus on the company’s emerging proteomics and spatial biology business. Bruker offered $1 per share, a 150% premium over the 40 cents per share closing price of Phenomex stock on Aug. 16. The all-cash transaction is slated to close in the fourth quarter of 2023.